NEW YORK — Mawi DNA Technologies said on Tuesday that it has signed a distribution agreement for its iSWAB biosampling products in certain European markets with Nucleus Biotech.
Under the terms of the deal, Heidelberg-based Nucleus will distribute the products in Germany, Austria, and Switzerland. Additional terms were not disclosed.
"Expanding our international presence is a key strategic component of Mawi's next phase of growth," Jerome David, VP of sales and marketing at Mawi, said in a statement. "We believe partnering with Nucleus Biotech will help us achieve this objective."
Mawi's iSWAB line of biospecimen collection devices include the company's flagship iSWAB-DNA for the collection of long-fragment double-stranded DNA from buccal cells, as well as iSWAB-Microbiome for microbial content in gut, rectal, vaginal, skin, oral, or soil samples. Mawi also offers iSWAB kits for the collection of RNA, blood, animal DNA, and protein.
In early 2019, Hayward, California-based Mawi signed a distribution agreement for its iSWAB products in the Middle East, Africa, and parts of Central and South Asia with Alliance Global.